Covid-19 Impact on Global Antibiotic Resistance Market Insights, Forecast to 2026
Antibiotic are medicines that are used to prevent various bacterial infections and antibiotic resistance is the inability of a microorganism to withstand the effects of an antibiotic. It is a specific type of drug resistance. These bacteria may infect humans and animals body, and the infections they cause are harder to treat than those caused by non-resistant bacteria. Hence, antibiotic resistance leads to higher medical costs and increased mortality.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Antibiotic Resistance market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Antibiotic Resistance industry.
Based on our recent survey, we have several different scenarios about the Antibiotic Resistance YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Antibiotic Resistance will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antibiotic Resistance market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antibiotic Resistance market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Antibiotic Resistance market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Antibiotic Resistance market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Antibiotic Resistance market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Antibiotic Resistance market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antibiotic Resistance market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antibiotic Resistance market.
The following manufacturers are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Antibiotic Resistance market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Antibiotic Resistance industry.
Based on our recent survey, we have several different scenarios about the Antibiotic Resistance YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Antibiotic Resistance will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antibiotic Resistance market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antibiotic Resistance market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Antibiotic Resistance market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Antibiotic Resistance market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Antibiotic Resistance market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Antibiotic Resistance market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antibiotic Resistance market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antibiotic Resistance market.
The following manufacturers are covered in this report:
- Allergan
- AmpliPhi Biosciences
- BioVersys GmbH
- Macrolide Pharmaceuticals
- Melinta Therapeutics
- Merck
- Nabriva Therapeutics
- Nemesis Bioscience
- Phage Technologies S.A
- Tetraphase Pharmaceuticals
- The Medicines Company
- TPfizer
- Westway Health
- By Disease
- By Pathogen
- Oxazolidinones
- Lipoglycopeptides
- Tetracyclines
- Cephalosporins
- Combination therapies
- Other
1 STUDY COVERAGE
1.1 Antibiotic Resistance Product Introduction
1.2 Market Segments
1.3 Key Antibiotic Resistance Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Antibiotic Resistance Market Size Growth Rate by Type
1.4.2 Type I
1.4.3 Type II
1.5 Market by Application
1.5.1 Global Antibiotic Resistance Market Size Growth Rate by Application
1.5.2 Oxazolidinones
1.5.3 Lipoglycopeptides
1.5.4 Tetracyclines
1.5.5 Cephalosporins
1.5.6 Combination therapies
1.5.7 Other
1.6 Coronavirus Disease 2019 (Covid-19): Antibiotic Resistance Industry Impact
1.6.1 How the Covid-19 is Affecting the Antibiotic Resistance Industry
1.6.1.1 Antibiotic Resistance Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Antibiotic Resistance Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Antibiotic Resistance Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Antibiotic Resistance Market Size Estimates and Forecasts
2.1.1 Global Antibiotic Resistance Revenue 2015-2026
2.1.2 Global Antibiotic Resistance Sales 2015-2026
2.2 Antibiotic Resistance Market Size by Region: 2020 Versus 2026
2.2.1 Global Antibiotic Resistance Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Antibiotic Resistance Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL ANTIBIOTIC RESISTANCE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Antibiotic Resistance Sales by Manufacturers
3.1.1 Antibiotic Resistance Sales by Manufacturers (2015-2020)
3.1.2 Antibiotic Resistance Sales Market Share by Manufacturers (2015-2020)
3.2 Antibiotic Resistance Revenue by Manufacturers
3.2.1 Antibiotic Resistance Revenue by Manufacturers (2015-2020)
3.2.2 Antibiotic Resistance Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antibiotic Resistance Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Antibiotic Resistance Revenue in 2019
3.2.5 Global Antibiotic Resistance Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Antibiotic Resistance Price by Manufacturers
3.4 Antibiotic Resistance Manufacturing Base Distribution, Product Types
3.4.1 Antibiotic Resistance Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antibiotic Resistance Product Type
3.4.3 Date of International Manufacturers Enter into Antibiotic Resistance Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Antibiotic Resistance Market Size by Type (2015-2020)
4.1.1 Global Antibiotic Resistance Sales by Type (2015-2020)
4.1.2 Global Antibiotic Resistance Revenue by Type (2015-2020)
4.1.3 Antibiotic Resistance Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Antibiotic Resistance Market Size Forecast by Type (2021-2026)
4.2.1 Global Antibiotic Resistance Sales Forecast by Type (2021-2026)
4.2.2 Global Antibiotic Resistance Revenue Forecast by Type (2021-2026)
4.2.3 Antibiotic Resistance Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Antibiotic Resistance Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Antibiotic Resistance Market Size by Application (2015-2020)
5.1.1 Global Antibiotic Resistance Sales by Application (2015-2020)
5.1.2 Global Antibiotic Resistance Revenue by Application (2015-2020)
5.1.3 Antibiotic Resistance Price by Application (2015-2020)
5.2 Antibiotic Resistance Market Size Forecast by Application (2021-2026)
5.2.1 Global Antibiotic Resistance Sales Forecast by Application (2021-2026)
5.2.2 Global Antibiotic Resistance Revenue Forecast by Application (2021-2026)
5.2.3 Global Antibiotic Resistance Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Antibiotic Resistance by Country
6.1.1 North America Antibiotic Resistance Sales by Country
6.1.2 North America Antibiotic Resistance Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Antibiotic Resistance Market Facts & Figures by Type
6.3 North America Antibiotic Resistance Market Facts & Figures by Application
7 EUROPE
7.1 Europe Antibiotic Resistance by Country
7.1.1 Europe Antibiotic Resistance Sales by Country
7.1.2 Europe Antibiotic Resistance Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antibiotic Resistance Market Facts & Figures by Type
7.3 Europe Antibiotic Resistance Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Antibiotic Resistance by Region
8.1.1 Asia Pacific Antibiotic Resistance Sales by Region
8.1.2 Asia Pacific Antibiotic Resistance Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Antibiotic Resistance Market Facts & Figures by Type
8.3 Asia Pacific Antibiotic Resistance Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Antibiotic Resistance by Country
9.1.1 Latin America Antibiotic Resistance Sales by Country
9.1.2 Latin America Antibiotic Resistance Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Antibiotic Resistance Market Facts & Figures by Type
9.3 Central & South America Antibiotic Resistance Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Antibiotic Resistance by Country
10.1.1 Middle East and Africa Antibiotic Resistance Sales by Country
10.1.2 Middle East and Africa Antibiotic Resistance Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Antibiotic Resistance Market Facts & Figures by Type
10.3 Middle East and Africa Antibiotic Resistance Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Description, Business Overview and Total Revenue
11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Antibiotic Resistance Products Offered
11.1.5 Allergan Recent Development
11.2 AmpliPhi Biosciences
11.2.1 AmpliPhi Biosciences Corporation Information
11.2.2 AmpliPhi Biosciences Description, Business Overview and Total Revenue
11.2.3 AmpliPhi Biosciences Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AmpliPhi Biosciences Antibiotic Resistance Products Offered
11.2.5 AmpliPhi Biosciences Recent Development
11.3 BioVersys GmbH
11.3.1 BioVersys GmbH Corporation Information
11.3.2 BioVersys GmbH Description, Business Overview and Total Revenue
11.3.3 BioVersys GmbH Sales, Revenue and Gross Margin (2015-2020)
11.3.4 BioVersys GmbH Antibiotic Resistance Products Offered
11.3.5 BioVersys GmbH Recent Development
11.4 Macrolide Pharmaceuticals
11.4.1 Macrolide Pharmaceuticals Corporation Information
11.4.2 Macrolide Pharmaceuticals Description, Business Overview and Total Revenue
11.4.3 Macrolide Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Macrolide Pharmaceuticals Antibiotic Resistance Products Offered
11.4.5 Macrolide Pharmaceuticals Recent Development
11.5 Melinta Therapeutics
11.5.1 Melinta Therapeutics Corporation Information
11.5.2 Melinta Therapeutics Description, Business Overview and Total Revenue
11.5.3 Melinta Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Melinta Therapeutics Antibiotic Resistance Products Offered
11.5.5 Melinta Therapeutics Recent Development
11.6 Merck
11.6.1 Merck Corporation Information
11.6.2 Merck Description, Business Overview and Total Revenue
11.6.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Merck Antibiotic Resistance Products Offered
11.6.5 Merck Recent Development
11.7 Nabriva Therapeutics
11.7.1 Nabriva Therapeutics Corporation Information
11.7.2 Nabriva Therapeutics Description, Business Overview and Total Revenue
11.7.3 Nabriva Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Nabriva Therapeutics Antibiotic Resistance Products Offered
11.7.5 Nabriva Therapeutics Recent Development
11.8 Nemesis Bioscience
11.8.1 Nemesis Bioscience Corporation Information
11.8.2 Nemesis Bioscience Description, Business Overview and Total Revenue
11.8.3 Nemesis Bioscience Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Nemesis Bioscience Antibiotic Resistance Products Offered
11.8.5 Nemesis Bioscience Recent Development
11.9 Phage Technologies S.A
11.9.1 Phage Technologies S.A Corporation Information
11.9.2 Phage Technologies S.A Description, Business Overview and Total Revenue
11.9.3 Phage Technologies S.A Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Phage Technologies S.A Antibiotic Resistance Products Offered
11.9.5 Phage Technologies S.A Recent Development
11.10 Tetraphase Pharmaceuticals
11.10.1 Tetraphase Pharmaceuticals Corporation Information
11.10.2 Tetraphase Pharmaceuticals Description, Business Overview and Total Revenue
11.10.3 Tetraphase Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Tetraphase Pharmaceuticals Antibiotic Resistance Products Offered
11.10.5 Tetraphase Pharmaceuticals Recent Development
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Description, Business Overview and Total Revenue
11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Antibiotic Resistance Products Offered
11.1.5 Allergan Recent Development
11.12 TPfizer
11.12.1 TPfizer Corporation Information
11.12.2 TPfizer Description, Business Overview and Total Revenue
11.12.3 TPfizer Sales, Revenue and Gross Margin (2015-2020)
11.12.4 TPfizer Products Offered
11.12.5 TPfizer Recent Development
11.13 Westway Health
11.13.1 Westway Health Corporation Information
11.13.2 Westway Health Description, Business Overview and Total Revenue
11.13.3 Westway Health Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Westway Health Products Offered
11.13.5 Westway Health Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Antibiotic Resistance Market Estimates and Projections by Region
12.1.1 Global Antibiotic Resistance Sales Forecast by Regions 2021-2026
12.1.2 Global Antibiotic Resistance Revenue Forecast by Regions 2021-2026
12.2 North America Antibiotic Resistance Market Size Forecast (2021-2026)
12.2.1 North America: Antibiotic Resistance Sales Forecast (2021-2026)
12.2.2 North America: Antibiotic Resistance Revenue Forecast (2021-2026)
12.2.3 North America: Antibiotic Resistance Market Size Forecast by Country (2021-2026)
12.3 Europe Antibiotic Resistance Market Size Forecast (2021-2026)
12.3.1 Europe: Antibiotic Resistance Sales Forecast (2021-2026)
12.3.2 Europe: Antibiotic Resistance Revenue Forecast (2021-2026)
12.3.3 Europe: Antibiotic Resistance Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Antibiotic Resistance Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Antibiotic Resistance Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Antibiotic Resistance Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Antibiotic Resistance Market Size Forecast by Region (2021-2026)
12.5 Latin America Antibiotic Resistance Market Size Forecast (2021-2026)
12.5.1 Latin America: Antibiotic Resistance Sales Forecast (2021-2026)
12.5.2 Latin America: Antibiotic Resistance Revenue Forecast (2021-2026)
12.5.3 Latin America: Antibiotic Resistance Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Antibiotic Resistance Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Antibiotic Resistance Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Antibiotic Resistance Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Antibiotic Resistance Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Antibiotic Resistance Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Antibiotic Resistance Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Antibiotic Resistance Product Introduction
1.2 Market Segments
1.3 Key Antibiotic Resistance Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Antibiotic Resistance Market Size Growth Rate by Type
1.4.2 Type I
1.4.3 Type II
1.5 Market by Application
1.5.1 Global Antibiotic Resistance Market Size Growth Rate by Application
1.5.2 Oxazolidinones
1.5.3 Lipoglycopeptides
1.5.4 Tetracyclines
1.5.5 Cephalosporins
1.5.6 Combination therapies
1.5.7 Other
1.6 Coronavirus Disease 2019 (Covid-19): Antibiotic Resistance Industry Impact
1.6.1 How the Covid-19 is Affecting the Antibiotic Resistance Industry
1.6.1.1 Antibiotic Resistance Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Antibiotic Resistance Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Antibiotic Resistance Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Antibiotic Resistance Market Size Estimates and Forecasts
2.1.1 Global Antibiotic Resistance Revenue 2015-2026
2.1.2 Global Antibiotic Resistance Sales 2015-2026
2.2 Antibiotic Resistance Market Size by Region: 2020 Versus 2026
2.2.1 Global Antibiotic Resistance Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Antibiotic Resistance Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL ANTIBIOTIC RESISTANCE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Antibiotic Resistance Sales by Manufacturers
3.1.1 Antibiotic Resistance Sales by Manufacturers (2015-2020)
3.1.2 Antibiotic Resistance Sales Market Share by Manufacturers (2015-2020)
3.2 Antibiotic Resistance Revenue by Manufacturers
3.2.1 Antibiotic Resistance Revenue by Manufacturers (2015-2020)
3.2.2 Antibiotic Resistance Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antibiotic Resistance Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Antibiotic Resistance Revenue in 2019
3.2.5 Global Antibiotic Resistance Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Antibiotic Resistance Price by Manufacturers
3.4 Antibiotic Resistance Manufacturing Base Distribution, Product Types
3.4.1 Antibiotic Resistance Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antibiotic Resistance Product Type
3.4.3 Date of International Manufacturers Enter into Antibiotic Resistance Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Antibiotic Resistance Market Size by Type (2015-2020)
4.1.1 Global Antibiotic Resistance Sales by Type (2015-2020)
4.1.2 Global Antibiotic Resistance Revenue by Type (2015-2020)
4.1.3 Antibiotic Resistance Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Antibiotic Resistance Market Size Forecast by Type (2021-2026)
4.2.1 Global Antibiotic Resistance Sales Forecast by Type (2021-2026)
4.2.2 Global Antibiotic Resistance Revenue Forecast by Type (2021-2026)
4.2.3 Antibiotic Resistance Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Antibiotic Resistance Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Antibiotic Resistance Market Size by Application (2015-2020)
5.1.1 Global Antibiotic Resistance Sales by Application (2015-2020)
5.1.2 Global Antibiotic Resistance Revenue by Application (2015-2020)
5.1.3 Antibiotic Resistance Price by Application (2015-2020)
5.2 Antibiotic Resistance Market Size Forecast by Application (2021-2026)
5.2.1 Global Antibiotic Resistance Sales Forecast by Application (2021-2026)
5.2.2 Global Antibiotic Resistance Revenue Forecast by Application (2021-2026)
5.2.3 Global Antibiotic Resistance Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Antibiotic Resistance by Country
6.1.1 North America Antibiotic Resistance Sales by Country
6.1.2 North America Antibiotic Resistance Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Antibiotic Resistance Market Facts & Figures by Type
6.3 North America Antibiotic Resistance Market Facts & Figures by Application
7 EUROPE
7.1 Europe Antibiotic Resistance by Country
7.1.1 Europe Antibiotic Resistance Sales by Country
7.1.2 Europe Antibiotic Resistance Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antibiotic Resistance Market Facts & Figures by Type
7.3 Europe Antibiotic Resistance Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Antibiotic Resistance by Region
8.1.1 Asia Pacific Antibiotic Resistance Sales by Region
8.1.2 Asia Pacific Antibiotic Resistance Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Antibiotic Resistance Market Facts & Figures by Type
8.3 Asia Pacific Antibiotic Resistance Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Antibiotic Resistance by Country
9.1.1 Latin America Antibiotic Resistance Sales by Country
9.1.2 Latin America Antibiotic Resistance Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Antibiotic Resistance Market Facts & Figures by Type
9.3 Central & South America Antibiotic Resistance Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Antibiotic Resistance by Country
10.1.1 Middle East and Africa Antibiotic Resistance Sales by Country
10.1.2 Middle East and Africa Antibiotic Resistance Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Antibiotic Resistance Market Facts & Figures by Type
10.3 Middle East and Africa Antibiotic Resistance Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Description, Business Overview and Total Revenue
11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Antibiotic Resistance Products Offered
11.1.5 Allergan Recent Development
11.2 AmpliPhi Biosciences
11.2.1 AmpliPhi Biosciences Corporation Information
11.2.2 AmpliPhi Biosciences Description, Business Overview and Total Revenue
11.2.3 AmpliPhi Biosciences Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AmpliPhi Biosciences Antibiotic Resistance Products Offered
11.2.5 AmpliPhi Biosciences Recent Development
11.3 BioVersys GmbH
11.3.1 BioVersys GmbH Corporation Information
11.3.2 BioVersys GmbH Description, Business Overview and Total Revenue
11.3.3 BioVersys GmbH Sales, Revenue and Gross Margin (2015-2020)
11.3.4 BioVersys GmbH Antibiotic Resistance Products Offered
11.3.5 BioVersys GmbH Recent Development
11.4 Macrolide Pharmaceuticals
11.4.1 Macrolide Pharmaceuticals Corporation Information
11.4.2 Macrolide Pharmaceuticals Description, Business Overview and Total Revenue
11.4.3 Macrolide Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Macrolide Pharmaceuticals Antibiotic Resistance Products Offered
11.4.5 Macrolide Pharmaceuticals Recent Development
11.5 Melinta Therapeutics
11.5.1 Melinta Therapeutics Corporation Information
11.5.2 Melinta Therapeutics Description, Business Overview and Total Revenue
11.5.3 Melinta Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Melinta Therapeutics Antibiotic Resistance Products Offered
11.5.5 Melinta Therapeutics Recent Development
11.6 Merck
11.6.1 Merck Corporation Information
11.6.2 Merck Description, Business Overview and Total Revenue
11.6.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Merck Antibiotic Resistance Products Offered
11.6.5 Merck Recent Development
11.7 Nabriva Therapeutics
11.7.1 Nabriva Therapeutics Corporation Information
11.7.2 Nabriva Therapeutics Description, Business Overview and Total Revenue
11.7.3 Nabriva Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Nabriva Therapeutics Antibiotic Resistance Products Offered
11.7.5 Nabriva Therapeutics Recent Development
11.8 Nemesis Bioscience
11.8.1 Nemesis Bioscience Corporation Information
11.8.2 Nemesis Bioscience Description, Business Overview and Total Revenue
11.8.3 Nemesis Bioscience Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Nemesis Bioscience Antibiotic Resistance Products Offered
11.8.5 Nemesis Bioscience Recent Development
11.9 Phage Technologies S.A
11.9.1 Phage Technologies S.A Corporation Information
11.9.2 Phage Technologies S.A Description, Business Overview and Total Revenue
11.9.3 Phage Technologies S.A Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Phage Technologies S.A Antibiotic Resistance Products Offered
11.9.5 Phage Technologies S.A Recent Development
11.10 Tetraphase Pharmaceuticals
11.10.1 Tetraphase Pharmaceuticals Corporation Information
11.10.2 Tetraphase Pharmaceuticals Description, Business Overview and Total Revenue
11.10.3 Tetraphase Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Tetraphase Pharmaceuticals Antibiotic Resistance Products Offered
11.10.5 Tetraphase Pharmaceuticals Recent Development
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Description, Business Overview and Total Revenue
11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Antibiotic Resistance Products Offered
11.1.5 Allergan Recent Development
11.12 TPfizer
11.12.1 TPfizer Corporation Information
11.12.2 TPfizer Description, Business Overview and Total Revenue
11.12.3 TPfizer Sales, Revenue and Gross Margin (2015-2020)
11.12.4 TPfizer Products Offered
11.12.5 TPfizer Recent Development
11.13 Westway Health
11.13.1 Westway Health Corporation Information
11.13.2 Westway Health Description, Business Overview and Total Revenue
11.13.3 Westway Health Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Westway Health Products Offered
11.13.5 Westway Health Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Antibiotic Resistance Market Estimates and Projections by Region
12.1.1 Global Antibiotic Resistance Sales Forecast by Regions 2021-2026
12.1.2 Global Antibiotic Resistance Revenue Forecast by Regions 2021-2026
12.2 North America Antibiotic Resistance Market Size Forecast (2021-2026)
12.2.1 North America: Antibiotic Resistance Sales Forecast (2021-2026)
12.2.2 North America: Antibiotic Resistance Revenue Forecast (2021-2026)
12.2.3 North America: Antibiotic Resistance Market Size Forecast by Country (2021-2026)
12.3 Europe Antibiotic Resistance Market Size Forecast (2021-2026)
12.3.1 Europe: Antibiotic Resistance Sales Forecast (2021-2026)
12.3.2 Europe: Antibiotic Resistance Revenue Forecast (2021-2026)
12.3.3 Europe: Antibiotic Resistance Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Antibiotic Resistance Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Antibiotic Resistance Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Antibiotic Resistance Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Antibiotic Resistance Market Size Forecast by Region (2021-2026)
12.5 Latin America Antibiotic Resistance Market Size Forecast (2021-2026)
12.5.1 Latin America: Antibiotic Resistance Sales Forecast (2021-2026)
12.5.2 Latin America: Antibiotic Resistance Revenue Forecast (2021-2026)
12.5.3 Latin America: Antibiotic Resistance Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Antibiotic Resistance Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Antibiotic Resistance Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Antibiotic Resistance Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Antibiotic Resistance Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Antibiotic Resistance Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Antibiotic Resistance Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Antibiotic Resistance Market Segments
Table 2. Ranking of Global Top Antibiotic Resistance Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Antibiotic Resistance Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Type I
Table 5. Major Manufacturers of Type II
Table 6. COVID-19 Impact Global Market: (Four Antibiotic Resistance Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Antibiotic Resistance Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Antibiotic Resistance Players to Combat Covid-19 Impact
Table 11. Global Antibiotic Resistance Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 12. Global Antibiotic Resistance Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 13. Global Antibiotic Resistance Sales by Regions 2015-2020 (K Pcs)
Table 14. Global Antibiotic Resistance Sales Market Share by Regions (2015-2020)
Table 15. Global Antibiotic Resistance Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Antibiotic Resistance Sales by Manufacturers (2015-2020) (K Pcs)
Table 17. Global Antibiotic Resistance Sales Share by Manufacturers (2015-2020)
Table 18. Global Antibiotic Resistance Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Antibiotic Resistance by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibiotic Resistance as of 2019)
Table 20. Antibiotic Resistance Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Antibiotic Resistance Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Antibiotic Resistance Price (2015-2020) (USD/Pcs)
Table 23. Antibiotic Resistance Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Antibiotic Resistance Product Type
Table 25. Date of International Manufacturers Enter into Antibiotic Resistance Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Antibiotic Resistance Sales by Type (2015-2020) (K Pcs)
Table 28. Global Antibiotic Resistance Sales Share by Type (2015-2020)
Table 29. Global Antibiotic Resistance Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Antibiotic Resistance Revenue Share by Type (2015-2020)
Table 31. Antibiotic Resistance Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 32. Global Antibiotic Resistance Sales by Application (2015-2020) (K Pcs)
Table 33. Global Antibiotic Resistance Sales Share by Application (2015-2020)
Table 34. North America Antibiotic Resistance Sales by Country (2015-2020) (K Pcs)
Table 35. North America Antibiotic Resistance Sales Market Share by Country (2015-2020)
Table 36. North America Antibiotic Resistance Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Antibiotic Resistance Revenue Market Share by Country (2015-2020)
Table 38. North America Antibiotic Resistance Sales by Type (2015-2020) (K Pcs)
Table 39. North America Antibiotic Resistance Sales Market Share by Type (2015-2020)
Table 40. North America Antibiotic Resistance Sales by Application (2015-2020) (K Pcs)
Table 41. North America Antibiotic Resistance Sales Market Share by Application (2015-2020)
Table 42. Europe Antibiotic Resistance Sales by Country (2015-2020) (K Pcs)
Table 43. Europe Antibiotic Resistance Sales Market Share by Country (2015-2020)
Table 44. Europe Antibiotic Resistance Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Antibiotic Resistance Revenue Market Share by Country (2015-2020)
Table 46. Europe Antibiotic Resistance Sales by Type (2015-2020) (K Pcs)
Table 47. Europe Antibiotic Resistance Sales Market Share by Type (2015-2020)
Table 48. Europe Antibiotic Resistance Sales by Application (2015-2020) (K Pcs)
Table 49. Europe Antibiotic Resistance Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Antibiotic Resistance Sales by Region (2015-2020) (K Pcs)
Table 51. Asia Pacific Antibiotic Resistance Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Antibiotic Resistance Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Antibiotic Resistance Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Antibiotic Resistance Sales by Type (2015-2020) (K Pcs)
Table 55. Asia Pacific Antibiotic Resistance Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Antibiotic Resistance Sales by Application (2015-2020) (K Pcs)
Table 57. Asia Pacific Antibiotic Resistance Sales Market Share by Application (2015-2020)
Table 58. Latin America Antibiotic Resistance Sales by Country (2015-2020) (K Pcs)
Table 59. Latin America Antibiotic Resistance Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Antibiotic Resistance Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Antibiotic Resistance Revenue Market Share by Country (2015-2020)
Table 62. Latin America Antibiotic Resistance Sales by Type (2015-2020) (K Pcs)
Table 63. Latin America Antibiotic Resistance Sales Market Share by Type (2015-2020)
Table 64. Latin America Antibiotic Resistance Sales by Application (2015-2020) (K Pcs)
Table 65. Latin America Antibiotic Resistance Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Antibiotic Resistance Sales by Country (2015-2020) (K Pcs)
Table 67. Middle East and Africa Antibiotic Resistance Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Antibiotic Resistance Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Antibiotic Resistance Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Antibiotic Resistance Sales by Type (2015-2020) (K Pcs)
Table 71. Middle East and Africa Antibiotic Resistance Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Antibiotic Resistance Sales by Application (2015-2020) (K Pcs)
Table 73. Middle East and Africa Antibiotic Resistance Sales Market Share by Application (2015-2020)
Table 74. Allergan Corporation Information
Table 75. Allergan Description and Major Businesses
Table 76. Allergan Antibiotic Resistance Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 77. Allergan Product
Table 78. Allergan Recent Development
Table 79. AmpliPhi Biosciences Corporation Information
Table 80. AmpliPhi Biosciences Description and Major Businesses
Table 81. AmpliPhi Biosciences Antibiotic Resistance Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 82. AmpliPhi Biosciences Product
Table 83. AmpliPhi Biosciences Recent Development
Table 84. BioVersys GmbH Corporation Information
Table 85. BioVersys GmbH Description and Major Businesses
Table 86. BioVersys GmbH Antibiotic Resistance Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 87. BioVersys GmbH Product
Table 88. BioVersys GmbH Recent Development
Table 89. Macrolide Pharmaceuticals Corporation Information
Table 90. Macrolide Pharmaceuticals Description and Major Businesses
Table 91. Macrolide Pharmaceuticals Antibiotic Resistance Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 92. Macrolide Pharmaceuticals Product
Table 93. Macrolide Pharmaceuticals Recent Development
Table 94. Melinta Therapeutics Corporation Information
Table 95. Melinta Therapeutics Description and Major Businesses
Table 96. Melinta Therapeutics Antibiotic Resistance Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 97. Melinta Therapeutics Product
Table 98. Melinta Therapeutics Recent Development
Table 99. Merck Corporation Information
Table 100. Merck Description and Major Businesses
Table 101. Merck Antibiotic Resistance Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 102. Merck Product
Table 103. Merck Recent Development
Table 104. Nabriva Therapeutics Corporation Information
Table 105. Nabriva Therapeutics Description and Major Businesses
Table 106. Nabriva Therapeutics Antibiotic Resistance Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 107. Nabriva Therapeutics Product
Table 108. Nabriva Therapeutics Recent Development
Table 109. Nemesis Bioscience Corporation Information
Table 110. Nemesis Bioscience Description and Major Businesses
Table 111. Nemesis Bioscience Antibiotic Resistance Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Nemesis Bioscience Product
Table 113. Nemesis Bioscience Recent Development
Table 114. Phage Technologies S.A Corporation Information
Table 115. Phage Technologies S.A Description and Major Businesses
Table 116. Phage Technologies S.A Antibiotic Resistance Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Phage Technologies S.A Product
Table 118. Phage Technologies S.A Recent Development
Table 119. Tetraphase Pharmaceuticals Corporation Information
Table 120. Tetraphase Pharmaceuticals Description and Major Businesses
Table 121. Tetraphase Pharmaceuticals Antibiotic Resistance Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 122. Tetraphase Pharmaceuticals Product
Table 123. Tetraphase Pharmaceuticals Recent Development
Table 124. The Medicines Company Corporation Information
Table 125. The Medicines Company Description and Major Businesses
Table 126. The Medicines Company Antibiotic Resistance Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 127. The Medicines Company Product
Table 128. The Medicines Company Recent Development
Table 129. TPfizer Corporation Information
Table 130. TPfizer Description and Major Businesses
Table 131. TPfizer Antibiotic Resistance Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 132. TPfizer Product
Table 133. TPfizer Recent Development
Table 134. Westway Health Corporation Information
Table 135. Westway Health Description and Major Businesses
Table 136. Westway Health Antibiotic Resistance Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 137. Westway Health Product
Table 138. Westway Health Recent Development
Table 139. Global Antibiotic Resistance Sales Forecast by Regions (2021-2026) (K Pcs)
Table 140. Global Antibiotic Resistance Sales Market Share Forecast by Regions (2021-2026)
Table 141. Global Antibiotic Resistance Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 142. Global Antibiotic Resistance Revenue Market Share Forecast by Regions (2021-2026)
Table 143. North America: Antibiotic Resistance Sales Forecast by Country (2021-2026) (K Pcs)
Table 144. North America: Antibiotic Resistance Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Europe: Antibiotic Resistance Sales Forecast by Country (2021-2026) (K Pcs)
Table 146. Europe: Antibiotic Resistance Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Asia Pacific: Antibiotic Resistance Sales Forecast by Region (2021-2026) (K Pcs)
Table 148. Asia Pacific: Antibiotic Resistance Revenue Forecast by Region (2021-2026) (US$ Million)
Table 149. Latin America: Antibiotic Resistance Sales Forecast by Country (2021-2026) (K Pcs)
Table 150. Latin America: Antibiotic Resistance Revenue Forecast by Country (2021-2026) (US$ Million)
Table 151. Middle East and Africa: Antibiotic Resistance Sales Forecast by Country (2021-2026) (K Pcs)
Table 152. Middle East and Africa: Antibiotic Resistance Revenue Forecast by Country (2021-2026) (US$ Million)
Table 153. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 154. Key Challenges
Table 155. Market Risks
Table 156. Main Points Interviewed from Key Antibiotic Resistance Players
Table 157. Antibiotic Resistance Customers List
Table 158. Antibiotic Resistance Distributors List
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
Table 1. Antibiotic Resistance Market Segments
Table 2. Ranking of Global Top Antibiotic Resistance Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Antibiotic Resistance Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Type I
Table 5. Major Manufacturers of Type II
Table 6. COVID-19 Impact Global Market: (Four Antibiotic Resistance Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Antibiotic Resistance Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Antibiotic Resistance Players to Combat Covid-19 Impact
Table 11. Global Antibiotic Resistance Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 12. Global Antibiotic Resistance Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 13. Global Antibiotic Resistance Sales by Regions 2015-2020 (K Pcs)
Table 14. Global Antibiotic Resistance Sales Market Share by Regions (2015-2020)
Table 15. Global Antibiotic Resistance Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Antibiotic Resistance Sales by Manufacturers (2015-2020) (K Pcs)
Table 17. Global Antibiotic Resistance Sales Share by Manufacturers (2015-2020)
Table 18. Global Antibiotic Resistance Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Antibiotic Resistance by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibiotic Resistance as of 2019)
Table 20. Antibiotic Resistance Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Antibiotic Resistance Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Antibiotic Resistance Price (2015-2020) (USD/Pcs)
Table 23. Antibiotic Resistance Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Antibiotic Resistance Product Type
Table 25. Date of International Manufacturers Enter into Antibiotic Resistance Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Antibiotic Resistance Sales by Type (2015-2020) (K Pcs)
Table 28. Global Antibiotic Resistance Sales Share by Type (2015-2020)
Table 29. Global Antibiotic Resistance Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Antibiotic Resistance Revenue Share by Type (2015-2020)
Table 31. Antibiotic Resistance Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 32. Global Antibiotic Resistance Sales by Application (2015-2020) (K Pcs)
Table 33. Global Antibiotic Resistance Sales Share by Application (2015-2020)
Table 34. North America Antibiotic Resistance Sales by Country (2015-2020) (K Pcs)
Table 35. North America Antibiotic Resistance Sales Market Share by Country (2015-2020)
Table 36. North America Antibiotic Resistance Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Antibiotic Resistance Revenue Market Share by Country (2015-2020)
Table 38. North America Antibiotic Resistance Sales by Type (2015-2020) (K Pcs)
Table 39. North America Antibiotic Resistance Sales Market Share by Type (2015-2020)
Table 40. North America Antibiotic Resistance Sales by Application (2015-2020) (K Pcs)
Table 41. North America Antibiotic Resistance Sales Market Share by Application (2015-2020)
Table 42. Europe Antibiotic Resistance Sales by Country (2015-2020) (K Pcs)
Table 43. Europe Antibiotic Resistance Sales Market Share by Country (2015-2020)
Table 44. Europe Antibiotic Resistance Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Antibiotic Resistance Revenue Market Share by Country (2015-2020)
Table 46. Europe Antibiotic Resistance Sales by Type (2015-2020) (K Pcs)
Table 47. Europe Antibiotic Resistance Sales Market Share by Type (2015-2020)
Table 48. Europe Antibiotic Resistance Sales by Application (2015-2020) (K Pcs)
Table 49. Europe Antibiotic Resistance Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Antibiotic Resistance Sales by Region (2015-2020) (K Pcs)
Table 51. Asia Pacific Antibiotic Resistance Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Antibiotic Resistance Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Antibiotic Resistance Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Antibiotic Resistance Sales by Type (2015-2020) (K Pcs)
Table 55. Asia Pacific Antibiotic Resistance Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Antibiotic Resistance Sales by Application (2015-2020) (K Pcs)
Table 57. Asia Pacific Antibiotic Resistance Sales Market Share by Application (2015-2020)
Table 58. Latin America Antibiotic Resistance Sales by Country (2015-2020) (K Pcs)
Table 59. Latin America Antibiotic Resistance Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Antibiotic Resistance Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Antibiotic Resistance Revenue Market Share by Country (2015-2020)
Table 62. Latin America Antibiotic Resistance Sales by Type (2015-2020) (K Pcs)
Table 63. Latin America Antibiotic Resistance Sales Market Share by Type (2015-2020)
Table 64. Latin America Antibiotic Resistance Sales by Application (2015-2020) (K Pcs)
Table 65. Latin America Antibiotic Resistance Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Antibiotic Resistance Sales by Country (2015-2020) (K Pcs)
Table 67. Middle East and Africa Antibiotic Resistance Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Antibiotic Resistance Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Antibiotic Resistance Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Antibiotic Resistance Sales by Type (2015-2020) (K Pcs)
Table 71. Middle East and Africa Antibiotic Resistance Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Antibiotic Resistance Sales by Application (2015-2020) (K Pcs)
Table 73. Middle East and Africa Antibiotic Resistance Sales Market Share by Application (2015-2020)
Table 74. Allergan Corporation Information
Table 75. Allergan Description and Major Businesses
Table 76. Allergan Antibiotic Resistance Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 77. Allergan Product
Table 78. Allergan Recent Development
Table 79. AmpliPhi Biosciences Corporation Information
Table 80. AmpliPhi Biosciences Description and Major Businesses
Table 81. AmpliPhi Biosciences Antibiotic Resistance Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 82. AmpliPhi Biosciences Product
Table 83. AmpliPhi Biosciences Recent Development
Table 84. BioVersys GmbH Corporation Information
Table 85. BioVersys GmbH Description and Major Businesses
Table 86. BioVersys GmbH Antibiotic Resistance Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 87. BioVersys GmbH Product
Table 88. BioVersys GmbH Recent Development
Table 89. Macrolide Pharmaceuticals Corporation Information
Table 90. Macrolide Pharmaceuticals Description and Major Businesses
Table 91. Macrolide Pharmaceuticals Antibiotic Resistance Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 92. Macrolide Pharmaceuticals Product
Table 93. Macrolide Pharmaceuticals Recent Development
Table 94. Melinta Therapeutics Corporation Information
Table 95. Melinta Therapeutics Description and Major Businesses
Table 96. Melinta Therapeutics Antibiotic Resistance Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 97. Melinta Therapeutics Product
Table 98. Melinta Therapeutics Recent Development
Table 99. Merck Corporation Information
Table 100. Merck Description and Major Businesses
Table 101. Merck Antibiotic Resistance Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 102. Merck Product
Table 103. Merck Recent Development
Table 104. Nabriva Therapeutics Corporation Information
Table 105. Nabriva Therapeutics Description and Major Businesses
Table 106. Nabriva Therapeutics Antibiotic Resistance Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 107. Nabriva Therapeutics Product
Table 108. Nabriva Therapeutics Recent Development
Table 109. Nemesis Bioscience Corporation Information
Table 110. Nemesis Bioscience Description and Major Businesses
Table 111. Nemesis Bioscience Antibiotic Resistance Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Nemesis Bioscience Product
Table 113. Nemesis Bioscience Recent Development
Table 114. Phage Technologies S.A Corporation Information
Table 115. Phage Technologies S.A Description and Major Businesses
Table 116. Phage Technologies S.A Antibiotic Resistance Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Phage Technologies S.A Product
Table 118. Phage Technologies S.A Recent Development
Table 119. Tetraphase Pharmaceuticals Corporation Information
Table 120. Tetraphase Pharmaceuticals Description and Major Businesses
Table 121. Tetraphase Pharmaceuticals Antibiotic Resistance Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 122. Tetraphase Pharmaceuticals Product
Table 123. Tetraphase Pharmaceuticals Recent Development
Table 124. The Medicines Company Corporation Information
Table 125. The Medicines Company Description and Major Businesses
Table 126. The Medicines Company Antibiotic Resistance Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 127. The Medicines Company Product
Table 128. The Medicines Company Recent Development
Table 129. TPfizer Corporation Information
Table 130. TPfizer Description and Major Businesses
Table 131. TPfizer Antibiotic Resistance Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 132. TPfizer Product
Table 133. TPfizer Recent Development
Table 134. Westway Health Corporation Information
Table 135. Westway Health Description and Major Businesses
Table 136. Westway Health Antibiotic Resistance Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 137. Westway Health Product
Table 138. Westway Health Recent Development
Table 139. Global Antibiotic Resistance Sales Forecast by Regions (2021-2026) (K Pcs)
Table 140. Global Antibiotic Resistance Sales Market Share Forecast by Regions (2021-2026)
Table 141. Global Antibiotic Resistance Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 142. Global Antibiotic Resistance Revenue Market Share Forecast by Regions (2021-2026)
Table 143. North America: Antibiotic Resistance Sales Forecast by Country (2021-2026) (K Pcs)
Table 144. North America: Antibiotic Resistance Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Europe: Antibiotic Resistance Sales Forecast by Country (2021-2026) (K Pcs)
Table 146. Europe: Antibiotic Resistance Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Asia Pacific: Antibiotic Resistance Sales Forecast by Region (2021-2026) (K Pcs)
Table 148. Asia Pacific: Antibiotic Resistance Revenue Forecast by Region (2021-2026) (US$ Million)
Table 149. Latin America: Antibiotic Resistance Sales Forecast by Country (2021-2026) (K Pcs)
Table 150. Latin America: Antibiotic Resistance Revenue Forecast by Country (2021-2026) (US$ Million)
Table 151. Middle East and Africa: Antibiotic Resistance Sales Forecast by Country (2021-2026) (K Pcs)
Table 152. Middle East and Africa: Antibiotic Resistance Revenue Forecast by Country (2021-2026) (US$ Million)
Table 153. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 154. Key Challenges
Table 155. Market Risks
Table 156. Main Points Interviewed from Key Antibiotic Resistance Players
Table 157. Antibiotic Resistance Customers List
Table 158. Antibiotic Resistance Distributors List
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Antibiotic Resistance Product Picture
Figure 2. Global Antibiotic Resistance Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Antibiotic Resistance Sales Market Share by Application in 2020 & 2026
Figure 6. Oxazolidinones
Figure 7. Lipoglycopeptides
Figure 8. Tetracyclines
Figure 9. Cephalosporins
Figure 10. Combination therapies
Figure 11. Other
Figure 12. Antibiotic Resistance Report Years Considered
Figure 13. Global Antibiotic Resistance Market Size 2015-2026 (US$ Million)
Figure 14. Global Antibiotic Resistance Sales 2015-2026 (K Pcs)
Figure 15. Global Antibiotic Resistance Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Antibiotic Resistance Sales Market Share by Region (2015-2020)
Figure 17. Global Antibiotic Resistance Sales Market Share by Region in 2019
Figure 18. Global Antibiotic Resistance Revenue Market Share by Region (2015-2020)
Figure 19. Global Antibiotic Resistance Revenue Market Share by Region in 2019
Figure 20. Global Antibiotic Resistance Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Antibiotic Resistance Revenue in 2019
Figure 22. Antibiotic Resistance Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Antibiotic Resistance Sales Market Share by Type (2015-2020)
Figure 24. Global Antibiotic Resistance Sales Market Share by Type in 2019
Figure 25. Global Antibiotic Resistance Revenue Market Share by Type (2015-2020)
Figure 26. Global Antibiotic Resistance Revenue Market Share by Type in 2019
Figure 27. Global Antibiotic Resistance Market Share by Price Range (2015-2020)
Figure 28. Global Antibiotic Resistance Sales Market Share by Application (2015-2020)
Figure 29. Global Antibiotic Resistance Sales Market Share by Application in 2019
Figure 30. Global Antibiotic Resistance Revenue Market Share by Application (2015-2020)
Figure 31. Global Antibiotic Resistance Revenue Market Share by Application in 2019
Figure 32. North America Antibiotic Resistance Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Antibiotic Resistance Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Antibiotic Resistance Sales Market Share by Country in 2019
Figure 35. North America Antibiotic Resistance Revenue Market Share by Country in 2019
Figure 36. U.S. Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Antibiotic Resistance Market Share by Type in 2019
Figure 41. North America Antibiotic Resistance Market Share by Application in 2019
Figure 42. Europe Antibiotic Resistance Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Antibiotic Resistance Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Antibiotic Resistance Sales Market Share by Country in 2019
Figure 45. Europe Antibiotic Resistance Revenue Market Share by Country in 2019
Figure 46. Germany Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Antibiotic Resistance Market Share by Type in 2019
Figure 57. Europe Antibiotic Resistance Market Share by Application in 2019
Figure 58. Asia Pacific Antibiotic Resistance Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Antibiotic Resistance Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Antibiotic Resistance Sales Market Share by Region in 2019
Figure 61. Asia Pacific Antibiotic Resistance Revenue Market Share by Region in 2019
Figure 62. China Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Antibiotic Resistance Market Share by Type in 2019
Figure 85. Asia Pacific Antibiotic Resistance Market Share by Application in 2019
Figure 86. Latin America Antibiotic Resistance Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Antibiotic Resistance Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Antibiotic Resistance Sales Market Share by Country in 2019
Figure 89. Latin America Antibiotic Resistance Revenue Market Share by Country in 2019
Figure 90. Mexico Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Antibiotic Resistance Market Share by Type in 2019
Figure 97. Latin America Antibiotic Resistance Market Share by Application in 2019
Figure 98. Middle East and Africa Antibiotic Resistance Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Antibiotic Resistance Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Antibiotic Resistance Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Antibiotic Resistance Revenue Market Share by Country in 2019
Figure 102. Turkey Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Antibiotic Resistance Market Share by Type in 2019
Figure 109. Middle East and Africa Antibiotic Resistance Market Share by Application in 2019
Figure 110. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. AmpliPhi Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. BioVersys GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Macrolide Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Melinta Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Nabriva Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Nemesis Bioscience Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Phage Technologies S.A Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Tetraphase Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. The Medicines Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. TPfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. Westway Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. North America Antibiotic Resistance Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 124. North America Antibiotic Resistance Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Europe Antibiotic Resistance Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 126. Europe Antibiotic Resistance Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Asia Pacific Antibiotic Resistance Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 128. Asia Pacific Antibiotic Resistance Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Latin America Antibiotic Resistance Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 130. Latin America Antibiotic Resistance Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Middle East and Africa Antibiotic Resistance Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 132. Middle East and Africa Antibiotic Resistance Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 133. Porter's Five Forces Analysis
Figure 134. Channels of Distribution
Figure 135. Distributors Profiles
Figure 136. Bottom-up and Top-down Approaches for This Report
Figure 137. Data Triangulation
Figure 138. Key Executives Interviewed
Figure 1. Antibiotic Resistance Product Picture
Figure 2. Global Antibiotic Resistance Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Antibiotic Resistance Sales Market Share by Application in 2020 & 2026
Figure 6. Oxazolidinones
Figure 7. Lipoglycopeptides
Figure 8. Tetracyclines
Figure 9. Cephalosporins
Figure 10. Combination therapies
Figure 11. Other
Figure 12. Antibiotic Resistance Report Years Considered
Figure 13. Global Antibiotic Resistance Market Size 2015-2026 (US$ Million)
Figure 14. Global Antibiotic Resistance Sales 2015-2026 (K Pcs)
Figure 15. Global Antibiotic Resistance Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Antibiotic Resistance Sales Market Share by Region (2015-2020)
Figure 17. Global Antibiotic Resistance Sales Market Share by Region in 2019
Figure 18. Global Antibiotic Resistance Revenue Market Share by Region (2015-2020)
Figure 19. Global Antibiotic Resistance Revenue Market Share by Region in 2019
Figure 20. Global Antibiotic Resistance Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Antibiotic Resistance Revenue in 2019
Figure 22. Antibiotic Resistance Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Antibiotic Resistance Sales Market Share by Type (2015-2020)
Figure 24. Global Antibiotic Resistance Sales Market Share by Type in 2019
Figure 25. Global Antibiotic Resistance Revenue Market Share by Type (2015-2020)
Figure 26. Global Antibiotic Resistance Revenue Market Share by Type in 2019
Figure 27. Global Antibiotic Resistance Market Share by Price Range (2015-2020)
Figure 28. Global Antibiotic Resistance Sales Market Share by Application (2015-2020)
Figure 29. Global Antibiotic Resistance Sales Market Share by Application in 2019
Figure 30. Global Antibiotic Resistance Revenue Market Share by Application (2015-2020)
Figure 31. Global Antibiotic Resistance Revenue Market Share by Application in 2019
Figure 32. North America Antibiotic Resistance Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Antibiotic Resistance Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Antibiotic Resistance Sales Market Share by Country in 2019
Figure 35. North America Antibiotic Resistance Revenue Market Share by Country in 2019
Figure 36. U.S. Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Antibiotic Resistance Market Share by Type in 2019
Figure 41. North America Antibiotic Resistance Market Share by Application in 2019
Figure 42. Europe Antibiotic Resistance Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Antibiotic Resistance Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Antibiotic Resistance Sales Market Share by Country in 2019
Figure 45. Europe Antibiotic Resistance Revenue Market Share by Country in 2019
Figure 46. Germany Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Antibiotic Resistance Market Share by Type in 2019
Figure 57. Europe Antibiotic Resistance Market Share by Application in 2019
Figure 58. Asia Pacific Antibiotic Resistance Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Antibiotic Resistance Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Antibiotic Resistance Sales Market Share by Region in 2019
Figure 61. Asia Pacific Antibiotic Resistance Revenue Market Share by Region in 2019
Figure 62. China Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Antibiotic Resistance Market Share by Type in 2019
Figure 85. Asia Pacific Antibiotic Resistance Market Share by Application in 2019
Figure 86. Latin America Antibiotic Resistance Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Antibiotic Resistance Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Antibiotic Resistance Sales Market Share by Country in 2019
Figure 89. Latin America Antibiotic Resistance Revenue Market Share by Country in 2019
Figure 90. Mexico Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Antibiotic Resistance Market Share by Type in 2019
Figure 97. Latin America Antibiotic Resistance Market Share by Application in 2019
Figure 98. Middle East and Africa Antibiotic Resistance Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Antibiotic Resistance Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Antibiotic Resistance Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Antibiotic Resistance Revenue Market Share by Country in 2019
Figure 102. Turkey Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Antibiotic Resistance Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Antibiotic Resistance Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Antibiotic Resistance Market Share by Type in 2019
Figure 109. Middle East and Africa Antibiotic Resistance Market Share by Application in 2019
Figure 110. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. AmpliPhi Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. BioVersys GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Macrolide Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Melinta Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Nabriva Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Nemesis Bioscience Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Phage Technologies S.A Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Tetraphase Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. The Medicines Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. TPfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. Westway Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. North America Antibiotic Resistance Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 124. North America Antibiotic Resistance Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Europe Antibiotic Resistance Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 126. Europe Antibiotic Resistance Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Asia Pacific Antibiotic Resistance Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 128. Asia Pacific Antibiotic Resistance Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Latin America Antibiotic Resistance Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 130. Latin America Antibiotic Resistance Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Middle East and Africa Antibiotic Resistance Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 132. Middle East and Africa Antibiotic Resistance Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 133. Porter's Five Forces Analysis
Figure 134. Channels of Distribution
Figure 135. Distributors Profiles
Figure 136. Bottom-up and Top-down Approaches for This Report
Figure 137. Data Triangulation
Figure 138. Key Executives Interviewed
